Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.
July 14, 2020 07:00 ET
|
Arch Biopartners
Multi-center, Randomized, Double-Blind, Placebo-Controlled Clinical study targeting the prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury (AKI) in Patients Infected with...
New book reveals ‘The Divine Cure of Coronavirus and Widespread Diseases’
July 14, 2020 01:10 ET
|
Partridge Singapore
DUBAI, United Arab Emirates, July 14, 2020 (GLOBE NEWSWIRE) -- In her previous publication titled “Disease is an Expiation of the Sins,” Dr. Mira Bajirova explains that the diseases inflicted to...
Association of American Physicians and Surgeons (AAPS) Suggests Different Approach to COVID-19 Surge
July 13, 2020 16:31 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., July 13, 2020 (GLOBE NEWSWIRE) -- As COVID-19 surges in border states, the Association of American Physicians and Surgeons (AAPS) calls on governors to consider the approach used for...
Hy-Lite Responds to Social Distancing Needs with Launch of Acrylic Block Rolling Privacy Panels
July 13, 2020 11:14 ET
|
Hy-Lite
PENSACOLA, Florida, July 13, 2020 (GLOBE NEWSWIRE) -- To support social distancing in medical, workplace and commercial spaces, Hy-Lite has introduced a line of Acrylic Block Rolling Privacy Panels....
Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
July 13, 2020 08:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides perspectives on the planned...
Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
July 13, 2020 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Research to Develop Live Replicating Vaccine (TNX-2300) to Protect Against COVID-19 Based on Bovine Parainfluenza Virus TNX-2300 Will Be Tonix’s Second Live Replicating Virus Vaccine Platform ...
Pfizer und BioNTech erhalten FDA-Fast-Track-Status für zwei mRNA-basierte Impfstoffkandidaten gegen SARS-CoV-2
July 13, 2020 06:45 ET
|
BioNTech SE
NEW YORK und MAINZ, Deutschland, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) gaben heute bekannt, dass zwei der vier in Entwicklung...
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
July 13, 2020 06:45 ET
|
BioNTech SE
NEW YORK and MAINZ, Germany, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that two of the companies’ four investigational...
Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency’s suggestion
July 13, 2020 06:00 ET
|
CytoDyn Inc.
Update on COVID-19: CytoDyn is planning to lock and unblind the Phase 2 COVID-19 trial data later this week. Periodic safety review by Data Safety Monitoring Committee (DSMC) for ongoing Phase 3 study...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
July 13, 2020 03:30 ET
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...